DS
ONC

DRW Securities’s BeOne Medicines Ltd ONC Stock Holding History

DRW Securities’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$493K Buy
+1,731
New +$510K 0.01% 436
2025
Q4 		– Sell
-2,653
Closed -$906K – 1801
2025
Q3 		$906K Buy
+2,653
New +$806K 0.02% 411
2024
Q4 		– Sell
-2,553
Closed -$573K – 817
2024
Q3 		$573K Buy
+2,553
New +$459K 0.02% 352

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

DRW Securities's ONC Position: Q2 2026 in Review

DRW Securities opened a new position in BeOne Medicines Ltd (ONC) in Q2 2026: 1,731 shares worth $493K. The stake represents 0.01% of the portfolio and ranks #436 among its holdings. This is a return to the name: DRW Securities previously reported a position in ONC as recently as Q3 2025.

DRW Securities first reported a position in ONC in Q3 2024 and has held it in 3 quarters since. The position peaked at $906K in Q3 2025. 283 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • DRW Securities held 1,731 shares of BeOne Medicines Ltd worth $493K as of Q2 2026.
  • BeOne Medicines Ltd was a new DRW Securities position in Q2 2026.
  • BeOne Medicines Ltd made up 0.01% of DRW Securities's portfolio in Q2 2026, its #436 holding.
  • DRW Securities first reported a position in BeOne Medicines Ltd in Q3 2024 and has held it in 3 quarters since.
  • DRW Securities's BeOne Medicines Ltd position peaked at $906K in Q3 2025.
  • 283 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.